US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Pharmaceuticals Market Research Reports & Industry Analysis

  • Biopharmaceuticals (266)
  • Diseases & Conditions (4134)
  • Drug Delivery (287)
  • Therapeutic Area (7364)
  • Vaccines (727)
RSS Feeds

Pharmaceuticals Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
Biopharmaceutical and Vaccine Production Markets
8/29/2014 | published by: Kalorama Information
... final stages of clinical drug testing for new biopharmaceuticals, as manufacturers decide when and how to risk production capital to upscale while anticipating FDA or EMA approval. During the past five years, estimates for biopharmaceuticals ...  |  read more...
USD 3,995
Breast Cancer Screening (Mammography, MRI & Ultrasound) Market & Forecast – Worldwide
9/9/2014 | published by: Renub Research
... in double digit Billion US$ for 2013. United States is the leading market for breast cancer screening globally. China is expected to maintain its 2nd position in the forecasting period due to hefty number of ...  |  read more...
USD 1,490
Herbal/Traditional Products - Tunisia
9/12/2014 | published by: Euromonitor International
... shows a strong preference for standard products, increasingly focusing on affordable standard generics during the review period. Consequently, only a limited product range is available in herbal/traditional products. This includes topical analgesics/anaesthetic, medicated confectionery, cough/cold... ...  |  read more...
USD 900
Zosano, Inc. - Product Pipeline Review - 2014
9/10/2014 | published by: Global Markets Direct
... This report provides comprehensive information on the current therapeutic developmental pipeline of Zosano Pharma, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) ...  |  read more...
USD 1,500
ObeTherapy Biotechnology - Product Pipeline Review - 2014
9/10/2014 | published by: Global Markets Direct
... provides comprehensive information on the current therapeutic developmental pipeline of ObeTherapy Biotechnology’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
USD 1,500
Phenex Pharmaceuticals AG - Product Pipeline Review - 2014
9/10/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Phenex Pharmaceuticals AG’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Physica Pharma - Product Pipeline Review - 2014
9/10/2014 | published by: Global Markets Direct
... provides comprehensive information on the current therapeutic developmental pipeline of Physica Pharma’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
USD 1,500
Q Chip Ltd. - Product Pipeline Review - 2014
9/10/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Q Chip Ltd.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Ascendis Pharma A/S - Product Pipeline Review - 2014
9/10/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Ascendis Pharma A/S’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
BerGenBio AS - Product Pipeline Review - 2014
9/10/2014 | published by: Global Markets Direct
... provides comprehensive information on the current therapeutic developmental pipeline of BerGenBio AS’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
USD 1,500
Acumen Pharmaceuticals, Inc. - Product Pipeline Review - 2014
9/10/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Acumen Pharmaceuticals, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Neurotech Pharmaceuticals, Inc. - Product Pipeline Review - 2014
9/10/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Neurotech Pharmaceuticals, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
TARIS BioMedical, Inc. - Product Pipeline Review - 2014
9/10/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of TARIS BioMedical, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Iron Deficiency Anemia - Pipeline Review, H2 2014
9/10/2014 | published by: Global Markets Direct
... information on the therapeutic development for Iron Deficiency Anemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Dystonia - Pipeline Review, H2 2014
9/10/2014 | published by: Global Markets Direct
... Dystonia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Lyme Disease - Pipeline Review, H2 2014
9/10/2014 | published by: Global Markets Direct
... therapeutic development for Lyme Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Infections Caused By Picornaviridae - Pipeline Review, H2 2014
9/10/2014 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutic development for Infections Caused By Picornaviridae, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
USD 2,000
Influenza A And B Infections - Pipeline Review, H2 2014
9/10/2014 | published by: Global Markets Direct
... therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Influenza A And B Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of ...  |  read more...
USD 2,000
Burkitt Lymphoma - Pipeline Review, H2 2014
9/10/2014 | published by: Global Markets Direct
... therapeutic development for Burkitt Lymphoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Uterine Cancer - Pipeline Review, H2 2014
9/10/2014 | published by: Global Markets Direct
... therapeutic development for Uterine Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Hypogonadotropic Hypogonadism - Pipeline Review, H2 2014
9/10/2014 | published by: Global Markets Direct
... therapeutic development for Hypogonadotropic Hypogonadism, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Lipella Pharmaceuticals, Inc. - Product Pipeline Review - 2014
9/10/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Lipella Pharmaceuticals, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
FAES Farma SA - Product Pipeline Review - 2014
9/10/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of FAES Farma SA’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Genextra S.p.a. - Product Pipeline Review - 2014
9/10/2014 | published by: Global Markets Direct
... provides comprehensive information on the current therapeutic developmental pipeline of Genextra S.p.a.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
USD 1,500
Laboratoires Laprophan in Consumer Health (Morocco)
9/10/2014 | published by: Euromonitor International
... of the pioneers of innovation and its products are positioned at the upper end of the market. Therefore, it will continue focusing on higher end consumers by investing in quality products. It will also focus ...  |  read more...
USD 150
< prev 1    3  4  5  6  7  8  9  10